Search results for "Rotaviru"

showing 10 items of 175 documents

Secretion of the rotavirus VP8* protein inLactococcus lactis

2001

Secretion of the VP8* subunit of the VP4 capsid protein of rotavirus by Lactococcus lactis has been achieved. For this purpose, a secretion vector has been constructed with the lactococcal signal sequence AL9 and the VP8*-encoding gene fragment. The amount of VP8* secreted by L. lactis in the culture supernatant was quantified and visualised by Western blot. Furthermore, it was shown to retain its hemagglutination capability, indicating that the conformation of the secreted peptide may be retaining its biological activity.

Signal peptidebiologymedicine.diagnostic_testvirusesLactococcusProtein subunitLactococcus lactisbiology.organism_classificationmedicine.disease_causeMicrobiologyMicrobiologyCapsidWestern blotRotavirusGeneticsmedicineSecretionMolecular BiologyFEMS Microbiology Letters
researchProduct

Unexpected Modulation of Recall B and T Cell Responses after Immunization with Rotavirus-like Particles in the Presence of LT-R192G

2010

LT-R192G, a mutant of the thermolabile enterotoxin of E. coli, is a potent adjuvant of immunization. Immune responses are generally analyzed at the end of protocols including at least 2 administrations, but rarely after a prime. To investigate this point, we compared B and T cell responses in mice after one and two intrarectal immunizations with 2/6 rotavirus-like particles (2/6-VLP) and LT-R192G. After a boost, we found, an unexpected lower B cell expansion measured by flow cytometry, despite a secondary antibody response. We then analyzed CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) and CD4(+)CD25(+)Foxp3(-) helper T cells after in vitro (re)stimulation of mesenteric lymph node cells …

T-LymphocytesHealth Toxicology and Mutagenesismedicine.medical_treatmentT cellBacterial ToxinsDose-Response Relationship Immunologiclcsh:Medicinechemical and pharmacologic phenomenaBiologyToxicologyArticleregulatory T cellsEnterotoxinsMiceInterleukin 21Immune systemB-1a lymphocyteAdjuvants ImmunologicAntigenmedicineAnimalsIL-2 receptorCD25B cellB-LymphocytesMice Inbred BALB CB lymphocytemucosal immunizationEscherichia coli Proteinslcsh:RRotavirus VaccinesVirionFOXP3LT-R192Ghemic and immune systemsrotavirusmedicine.anatomical_structureFoxp3ImmunologyFemaleImmunizationAdjuvantToxins
researchProduct

Análisis filogenético de los genes VP7 y NSP4 de cepas de rotavirus de niños con gastroenteritis en Valencia y Castellón

2012

Las infecciones por rotavirus afectan principalmente en la edad pediátrica y constituyen la primera causa de gastroenteritis en niños. La importancia de estos estudios radica en el conocimiento de las variaciones de los tipos antigénicos circulantes y la aparición o emergencia de nuevos genotipos, lo cual puede influir en las estrategias de vacunación. El G9 de rotavirus genotipo fue reportado por primera vez en 1983 en los Estados Unidos, llegando a ser uno de los genotipos más frecuentes en todo el mundo. La proteína NSP4 tiene un interés especial, ya que tiene un papel importante en el proceso de maduración de los viriones, actuando como receptor intracelular para VP6. Por otra parte, es…

Virología molecularCIENCIAS MÉDICASRotavirus virus gastrointestinales análisis molecularvirusesvirus diseasesEpidemiología molecularCIENCIAS MÉDICAS::Ciencias clínicas::Microbiología clínica:Ciencias clínicas::Microbiología clínica [CIENCIAS MÉDICAS]
researchProduct

Aproximaciones moleculares al estudio de las interacciones de rotavirus y norovirus con el huésped

2020

Los norovirus humanos son los principales agentes etiológicos de gastroenteritis aguda en todo el mundo. Aunque los norovirus son muy diversos (se han detectado más de 30 genotipos en humanos), durante los últimos 40 años la mayoría de los brotes y epidemias han sido causados por cepas del genotipo GII.4, lo que plantea interrogantes sobre su persistencia en la población. Entre otras posibles explicaciones, se considera que la evasión inmunológica es la principal causa de su éxito. Para estudiar en detalle el reconocimiento y la evasión de anticuerpos, analizamos un epítopo conformacional reconocido por un anticuerpo monoclonal (3C3G3) mediante mutagénesis dirigida y resonancia superficial …

antígenos histosanguíneosrotavirusvirus entéricosUNESCO::CIENCIAS MÉDICASUNESCO::CIENCIAS DE LA VIDAnorovirus:CIENCIAS MÉDICAS [UNESCO]inmunologíacristalografía:CIENCIAS DE LA VIDA [UNESCO]secretor
researchProduct

Neutralizing antibodies against rotavirus produced in transgenically labelled purple tomatoes

2011

Edible fruits are inexpensive biofactories for human health-promoting molecules that can be ingested as crude extracts or partially purified formulations. We show here the production of a model human antibody for passive protection against the enteric pathogen rotavirus in transgenically labelled tomato fruits. Transgenic tomato plants expressing a recombinant human immunoglobulin A (hIgA_2A1) selected against the VP8* peptide of rotavirus SA11 strain were obtained. The amount of hIgA_2A1 protein reached 3.6 ± 0.8% of the total soluble protein in the fruit of the transformed plants. Minimally processed fruit-derived products suitable for oral intake showed anti-VP8* binding activity and str…

biologyfungifood and beveragesPlant ScienceAgrobacterium tumefaciensbiology.organism_classificationmedicine.disease_causeFusion proteinIn vitroVirusMicrobiologylaw.inventionAntirrhinum majusBiochemistrylawRotavirusRecombinant DNAmedicineGenetically modified tomatoAgronomy and Crop ScienceBiotechnologyPlant Biotechnology Journal
researchProduct

ID: 213

2015

The epithelium is the main entry point for many viruses, but the processes that protect barrier surfaces against viral infections are incompletely understood. Here we identified interleukin 22 (IL-22) produced by innate lymphoid cell group 3 (ILC3) as an amplifier of signaling via interferon- λ (IFN- λ ) , a synergism needed to curtail the replication of rotavirus, the leading cause of childhood gastroenteritis. Cooperation between the receptor for IL-22 and the receptor for IFN- λ , both of which were ‘preferentially’ expressed by intestinal epithelial cells (IECs), was required for optimal activation of the transcription factor STAT1 and expression of interferon-stimulated genes (ISGs). T…

biologymedicine.medical_treatmentImmunologyInnate lymphoid cellHematologyImmunotherapymedicine.disease_causeBiochemistryVirologyInterleukin 22Viral replicationInterferonRotavirusImmunologymedicinebiology.proteinImmunology and AllergySTAT1Molecular BiologyTranscription factormedicine.drugCytokine
researchProduct

Effect of poly(I).poly(C12U) (Ampligen) on enteric virus (rotavirus, poliovirus and Coxsackie B3 virus) infections

1994

The effects of poly(1)-poly(C 12 U) (Ampligen) on infections with enteric viruses (rotavirus, poliovirus and Coxsackie B3 virus) were studied in vitro. Ampligen exhibited antiviral activity against rotavirus, especially when treatment was performed prior to inoculation of the virus. It was partially effective against Coxsackie B3 virus, but not against poliovirus. It is suggested that the observed effects may be due to the production of interferon induced by Ampligen

biologyvirusesPoliovirusRhabdoviridaebiology.organism_classificationmedicine.disease_causeApplied Microbiology and BiotechnologyVirologyVirusIn vitroMicrobiologyVesicular stomatitis virusInterferonRotavirusmedicineEnterovirusmedicine.drugLetters in Applied Microbiology
researchProduct

Cost analysis of the first two year of universal mass vaccination against rotavirus in Sicily

2015

Background Rotavirus vaccination (RV) is recognized by international health authority as the best strategy to prevent rotavirus gastroenteritis (RVGE) in children. Costs of RVGE were estimated in several studies and were classified into direct and indirect costs, that should be further divided into Health care and social perspective. This study aims to evaluate RVGE hospitalization costs in Sicily, before and after universal mass RV (UMRV) introduction. Methods Cases of RVGE were defined as all hospitalizations with an ICD-9-CM diagnosis code of 008.61 on any diagnosis position among children aged 0 to 59 months. Data were obtained from Hospital discharge records (HDR) of the Health Regiona…

business.industryRotavirusPublic Health Environmental and Occupational HealthmedicineCost analysisMass vaccinationmedicine.disease_causebusinessSettore MED/42 - Igiene Generale E ApplicataVirologyRVGE rotavirus vaccination hospitalizations
researchProduct

Safety of in-neonatal intensive care unit administration of rotavirus vaccination among preterms

2020

Abstract Background Rotavirus is among the most common vaccine preventable illness in children under 5 years old. Despite increased severity of rotaviral illness in early infancy, most neonatal intensive care units (NICUs) do not administer rotavirus vaccination. The present project aims to evaluate the safety of in-neonatal intenive care unit administration of the monovalent live, attenuated rotavirus vaccination to preterm newborns in Sicily. Methods From the first of March 2018 within the six most important NICUs of Sicily (three located in Palermo, two in Catania and one in Messina), and under the scientific coordination of the University of Palermo and of the Regional Health Department…

medicine.medical_specialtyNeonatal intensive care unitbusiness.industryEmergency medicinePublic Health Environmental and Occupational HealthMedicinebusinessRotavirus vaccinationAdministration (government)European Journal of Public Health
researchProduct

Rotavirus gastroenteritis: epidemiological, clinical, therapeutic aspects and economic implications

2013

Results 114 cases were diagnosed with rotavirus gastroenteritis in 2011 and 122 cases in 2012, frequently in the colder months, sex ratio M/F 1.42/1 in 2011, 1.18/1 in 2012 and in the age group 1-3 (58.90% of cases). The clinical severity was assessed by Vesikari score: 91 cases admitted in 2011 (79.82%) and 112 cases admitted in 2012 (91.80%) presenting a medium/severe score. 15 cases presented neurological symptoms and also 15 cases had renal failure. Among the electrolyte disorders the most commonly found was hyponatremia ( 150mEq/L). The hospitalization costs of rotavirus gastroenteritis cases ranged from 58.60€ to 5345 RON (1243.02€).

medicine.medical_specialtyPediatricsPathologybusiness.industryRotavirus gastroenteritismedicine.diseaseMedical microbiologyInfectious DiseasesPoster PresentationEpidemiologyTropical medicineHospitalization costmedicineClinical severityHyponatremiabusinessBMC Infectious Diseases
researchProduct